" Efesovir " (FS-1) for COVID-19, Phase 2
Condition: Covid19 Intervention: Drug: Efesovir Sponsor: Scientific Center for Anti-infectious Drugs, Kazakhstan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2021 Category: Research Source Type: clinical trials
Organ-substituting Technologies in the Treatment of Heart and Pulmonary Failure
Conditions: Acute Respiratory Distress Syndrome; Septic Shock; Sepsis Interventions: Device: Cytokine adsorber filter; Device: Extracorporeal hemoperfusion cartridge Sponsors: National Research Center for Cardiac Surgery, Kazakhstan; Ministry of Education and Science, Republic of Kazakhstan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2021 Category: Research Source Type: clinical trials